HEADER ONCOPROTEIN 24-JUN-08 3DKF
TITLE STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH INHIBITOR
TITLE 2 SGX-523
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: HGF RECEPTOR, HGF/SF RECEPTOR, PROTO-ONCOGENE C-MET, SCATTER
COMPND 5 FACTOR RECEPTOR, SF RECEPTOR, TYROSINE-PROTEIN KINASE MET;
COMPND 6 ENGINEERED: YES;
COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: MET, HCG_38705, TCAG7.66;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108;
SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9;
SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS
KEYWDS DRUG DISCOVERY, C-MET KINASE, FRAGMENT BASED, MEMBRANE, RECEPTOR,
KEYWDS 2 TRANSMEMBRANE, ONCOPROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR J.HENDLE
REVDAT 6 21-FEB-24 3DKF 1 REMARK
REVDAT 5 10-FEB-21 3DKF 1 JRNL REMARK SEQADV
REVDAT 4 22-APR-15 3DKF 1 COMPND DBREF REMARK TITLE
REVDAT 4 2 1 VERSN
REVDAT 3 19-JAN-10 3DKF 1 JRNL
REVDAT 2 06-OCT-09 3DKF 1 JRNL
REVDAT 1 07-JUL-09 3DKF 0
JRNL AUTH S.G.BUCHANAN,J.HENDLE,P.S.LEE,C.R.SMITH,P.Y.BOUNAUD,
JRNL AUTH 2 K.A.JESSEN,C.M.TANG,N.H.HUSER,J.D.FELCE,K.J.FRONING,
JRNL AUTH 3 M.C.PETERMAN,B.E.AUBOL,S.F.GESSERT,J.M.SAUDER,K.D.SCHWINN,
JRNL AUTH 4 M.RUSSELL,I.A.ROONEY,J.ADAMS,B.C.LEON,T.H.DO,J.M.BLANEY,
JRNL AUTH 5 P.A.SPRENGELER,D.A.THOMPSON,L.SMYTH,L.A.PELLETIER,S.ATWELL,
JRNL AUTH 6 K.HOLME,S.R.WASSERMAN,S.EMTAGE,S.K.BURLEY,S.H.REICH
JRNL TITL SGX523 IS AN EXQUISITELY SELECTIVE, ATP-COMPETITIVE
JRNL TITL 2 INHIBITOR OF THE MET RECEPTOR TYROSINE KINASE WITH ANTITUMOR
JRNL TITL 3 ACTIVITY IN VIVO.
JRNL REF MOL.CANCER THER. V. 8 3181 2009
JRNL REFN ISSN 1535-7163
JRNL PMID 19934279
JRNL DOI 10.1158/1535-7163.MCT-09-0477
REMARK 2
REMARK 2 RESOLUTION. 1.80 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.99
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : NULL
REMARK 3 NUMBER OF REFLECTIONS : 24264
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : NULL
REMARK 3 R VALUE (WORKING + TEST SET) : NULL
REMARK 3 R VALUE (WORKING SET) : 0.191
REMARK 3 FREE R VALUE : 0.233
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2263
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 27
REMARK 3 SOLVENT ATOMS : 213
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.78
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): NULL
REMARK 3 ESU BASED ON FREE R VALUE (A): NULL
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA
REMARK 3 BOND LENGTH (A) : NULL ; NULL
REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL
REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL
REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL
REMARK 3
REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL
REMARK 3
REMARK 3 NON-BONDED CONTACT RESTRAINTS.
REMARK 3 SINGLE TORSION (A) : NULL ; NULL
REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL
REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL
REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL
REMARK 3
REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS.
REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL
REMARK 3 PLANAR (DEGREES) : NULL ; NULL
REMARK 3 STAGGERED (DEGREES) : NULL ; NULL
REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 3DKF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JUL-08.
REMARK 100 THE DEPOSITION ID IS D_1000048148.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 19-JAN-07
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 31-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97969
REMARK 200 MONOCHROMATOR : DIAMOND
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL
REMARK 200 DATA SCALING SOFTWARE : SCALA 3.2.5
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24264
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800
REMARK 200 RESOLUTION RANGE LOW (A) : 34.986
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 79.7
REMARK 200 DATA REDUNDANCY : 4.300
REMARK 200 R MERGE (I) : 0.05500
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 44.82
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 20% ISOPROPANOL, 200 MM AMMONIUM
REMARK 280 ACETATE, 100 MM TRIS, PH 7.5, VAPOR DIFFUSION, TEMPERATURE 292K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.54450
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.24100
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.33950
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.24100
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.54450
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.33950
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 1046
REMARK 465 SER A 1047
REMARK 465 LEU A 1048
REMARK 465 ASN A 1049
REMARK 465 LEU A 1098
REMARK 465 ASP A 1099
REMARK 465 ASN A 1100
REMARK 465 ASP A 1101
REMARK 465 GLY A 1102
REMARK 465 ASP A 1231
REMARK 465 LYS A 1232
REMARK 465 GLU A 1233
REMARK 465 PHE A 1234
REMARK 465 ASP A 1235
REMARK 465 SER A 1236
REMARK 465 VAL A 1237
REMARK 465 HIS A 1238
REMARK 465 ASN A 1239
REMARK 465 LYS A 1240
REMARK 465 THR A 1241
REMARK 465 GLY A 1242
REMARK 465 ALA A 1243
REMARK 465 GLY A 1362
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LEU A1058 CG CD1 CD2
REMARK 470 LEU A1062 CG CD1 CD2
REMARK 470 VAL A1063 CG1 CG2
REMARK 470 GLN A1064 CG CD OE1 NE2
REMARK 470 GLN A1067 CG CD OE1 NE2
REMARK 470 ASN A1081 CG OD1 ND2
REMARK 470 GLU A1082 CG CD OE1 OE2
REMARK 470 VAL A1083 CG1 CG2
REMARK 470 ARG A1086 CG CD NE CZ NH1 NH2
REMARK 470 LYS A1103 CG CD CE NZ
REMARK 470 LYS A1104 CG CD CE NZ
REMARK 470 GLU A1120 CG CD OE1 OE2
REMARK 470 GLN A1123 CG CD OE1 NE2
REMARK 470 GLU A1127 CG CD OE1 OE2
REMARK 470 ARG A1148 CG CD NE CZ NH1 NH2
REMARK 470 SER A1149 OG
REMARK 470 LYS A1244 CG CD CE NZ
REMARK 470 LYS A1259 CG CD CE NZ
REMARK 470 PHE A1290 CG CD1 CD2 CE1 CE2 CZ
REMARK 470 ASP A1291 CG OD1 OD2
REMARK 470 LYS A1360 CG CD CE NZ
REMARK 470 GLU A1361 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ARG A1203 -17.26 75.69
REMARK 500 ALA A1221 -153.90 -127.05
REMARK 500 ASP A1291 15.37 -141.97
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 2
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SX8 A 1
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3DKC RELATED DB: PDB
REMARK 900 STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH ATP
REMARK 900 RELATED ID: 3DKG RELATED DB: PDB
REMARK 900 STRUCTURE OF MUTANT(Y1248L) MET RECEPTOR TYROSINE KINASE IN COMPLEX
REMARK 900 WITH INHIBITOR SGX-523
DBREF 3DKF A 1049 1360 UNP P08581 MET_HUMAN 1049 1360
SEQADV 3DKF GLY A 1046 UNP P08581 EXPRESSION TAG
SEQADV 3DKF SER A 1047 UNP P08581 EXPRESSION TAG
SEQADV 3DKF LEU A 1048 UNP P08581 EXPRESSION TAG
SEQADV 3DKF PHE A 1194 UNP P08581 TYR 1194 ENGINEERED MUTATION
SEQADV 3DKF PHE A 1234 UNP P08581 TYR 1234 ENGINEERED MUTATION
SEQADV 3DKF ASP A 1235 UNP P08581 TYR 1235 ENGINEERED MUTATION
SEQADV 3DKF GLU A 1361 UNP P08581 EXPRESSION TAG
SEQADV 3DKF GLY A 1362 UNP P08581 EXPRESSION TAG
SEQRES 1 A 317 GLY SER LEU ASN THR VAL HIS ILE ASP LEU SER ALA LEU
SEQRES 2 A 317 ASN PRO GLU LEU VAL GLN ALA VAL GLN HIS VAL VAL ILE
SEQRES 3 A 317 GLY PRO SER SER LEU ILE VAL HIS PHE ASN GLU VAL ILE
SEQRES 4 A 317 GLY ARG GLY HIS PHE GLY CYS VAL TYR HIS GLY THR LEU
SEQRES 5 A 317 LEU ASP ASN ASP GLY LYS LYS ILE HIS CYS ALA VAL LYS
SEQRES 6 A 317 SER LEU ASN ARG ILE THR ASP ILE GLY GLU VAL SER GLN
SEQRES 7 A 317 PHE LEU THR GLU GLY ILE ILE MET LYS ASP PHE SER HIS
SEQRES 8 A 317 PRO ASN VAL LEU SER LEU LEU GLY ILE CYS LEU ARG SER
SEQRES 9 A 317 GLU GLY SER PRO LEU VAL VAL LEU PRO TYR MET LYS HIS
SEQRES 10 A 317 GLY ASP LEU ARG ASN PHE ILE ARG ASN GLU THR HIS ASN
SEQRES 11 A 317 PRO THR VAL LYS ASP LEU ILE GLY PHE GLY LEU GLN VAL
SEQRES 12 A 317 ALA LYS GLY MET LYS PHE LEU ALA SER LYS LYS PHE VAL
SEQRES 13 A 317 HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU ASP GLU
SEQRES 14 A 317 LYS PHE THR VAL LYS VAL ALA ASP PHE GLY LEU ALA ARG
SEQRES 15 A 317 ASP MET TYR ASP LYS GLU PHE ASP SER VAL HIS ASN LYS
SEQRES 16 A 317 THR GLY ALA LYS LEU PRO VAL LYS TRP MET ALA LEU GLU
SEQRES 17 A 317 SER LEU GLN THR GLN LYS PHE THR THR LYS SER ASP VAL
SEQRES 18 A 317 TRP SER PHE GLY VAL LEU LEU TRP GLU LEU MET THR ARG
SEQRES 19 A 317 GLY ALA PRO PRO TYR PRO ASP VAL ASN THR PHE ASP ILE
SEQRES 20 A 317 THR VAL TYR LEU LEU GLN GLY ARG ARG LEU LEU GLN PRO
SEQRES 21 A 317 GLU TYR CYS PRO ASP PRO LEU TYR GLU VAL MET LEU LYS
SEQRES 22 A 317 CYS TRP HIS PRO LYS ALA GLU MET ARG PRO SER PHE SER
SEQRES 23 A 317 GLU LEU VAL SER ARG ILE SER ALA ILE PHE SER THR PHE
SEQRES 24 A 317 ILE GLY GLU HIS TYR VAL HIS VAL ASN ALA THR TYR VAL
SEQRES 25 A 317 ASN VAL LYS GLU GLY
HET CL A 2 1
HET SX8 A 1 26
HETNAM CL CHLORIDE ION
HETNAM SX8 6-{[6-(1-METHYL-1H-PYRAZOL-4-YL)[1,2,4]TRIAZOLO[4,3-
HETNAM 2 SX8 B]PYRIDAZIN-3-YL]SULFANYL}QUINOLINE
FORMUL 2 CL CL 1-
FORMUL 3 SX8 C18 H13 N7 S
FORMUL 4 HOH *213(H2 O)
HELIX 1 1 ASP A 1054 LEU A 1058 5 5
HELIX 2 2 ASN A 1059 VAL A 1066 1 8
HELIX 3 3 GLN A 1067 VAL A 1070 5 4
HELIX 4 4 ASP A 1117 ASP A 1133 1 17
HELIX 5 5 ASP A 1164 ASN A 1171 1 8
HELIX 6 6 THR A 1177 LYS A 1198 1 22
HELIX 7 7 ALA A 1206 ARG A 1208 5 3
HELIX 8 8 PHE A 1223 ARG A 1227 5 5
HELIX 9 9 PRO A 1246 MET A 1250 5 5
HELIX 10 10 ALA A 1251 GLN A 1258 1 8
HELIX 11 11 THR A 1261 THR A 1278 1 18
HELIX 12 12 ASN A 1288 PHE A 1290 5 3
HELIX 13 13 ASP A 1291 GLN A 1298 1 8
HELIX 14 14 PRO A 1309 TRP A 1320 1 12
HELIX 15 15 LYS A 1323 ARG A 1327 5 5
HELIX 16 16 SER A 1329 THR A 1343 1 15
SHEET 1 A 5 ILE A1077 GLY A1087 0
SHEET 2 A 5 GLY A1090 LEU A1097 -1 O VAL A1092 N GLY A1085
SHEET 3 A 5 ILE A1105 LEU A1112 -1 O VAL A1109 N TYR A1093
SHEET 4 A 5 SER A1152 PRO A1158 -1 O LEU A1157 N ALA A1108
SHEET 5 A 5 GLY A1144 ARG A1148 -1 N CYS A1146 O LEU A1154
SHEET 1 B 2 CYS A1210 LEU A1212 0
SHEET 2 B 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211
SITE 1 AC1 4 LYS A1179 GLY A1346 GLU A1347 HIS A1348
SITE 1 AC2 12 ILE A1084 ALA A1108 PRO A1158 TYR A1159
SITE 2 AC2 12 MET A1160 ASP A1164 ARG A1208 MET A1211
SITE 3 AC2 12 ALA A1221 ASP A1222 ALA A1226 TYR A1230
CRYST1 43.089 46.679 158.482 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.023208 0.000000 0.000000 0.00000
SCALE2 0.000000 0.021423 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006310 0.00000